3Helix

Collagen Hybridizing Peptides (CHP)

3Helix is based in Salt Lake City, Utah. It was founded by Drs. Yang Li and Michael Yu based on the technology that they invented at the Johns Hopkins University.
Damage to collagen, the major component of nearly every human tissue, is a strong indication of connective tissue injury, as well as a variety of diseases. However, targeting damaged collagen is difficult with conventional technologies.
3Helix has developed a series of proprietary collagen hybridizing peptides (CHP) that directly target the damaged collagen molecule.


Applications for CHPs:

  • Histopathology
  • Collagen identification in SDS-PAGE
  • Tissue decellularization
  • Analysis of mechanical damage at the molecular level
  • Visualization of cell invasion within 3D culture
  • In vivo Imaging

 

 

https://www.3helix.com/

Show Product

Other Partners

Apop Biosciences

Apop Biosciences

Powering cell stress detection

Fujifilm Irvine Scientific

Fujifilm Irvine Scie...

Cell culture solutions

Assay Biotechnology

Assay Biotechnology

Modified Antibodies and ELISA Kits

NZYtech

NZYtech

Mastermixes and Kits for Life Science Research and Molecular Diagnostics

Pricella Biotechnology

Pricella Biotechnolo...

Cell Culture Media and Reagents